| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | - | - | - | - | - | - | - | - |
| Total Income - EUR | 609 | 1.219 | - | - | - | - | - | - | - | - |
| Total Expenses - EUR | 10.893 | 10.565 | - | - | - | - | - | - | - | - |
| Gross Profit/Loss - EUR | -10.284 | -9.346 | - | - | - | - | - | - | - | - |
| Net Profit/Loss - EUR | -10.284 | -9.346 | - | - | - | - | - | - | - | - |
| Employees | 0 | 0 | - | - | - | - | - | - | - | - |
Check the financial reports for the company - Amoun Pharmaceutical Romania Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | - | - | - | - | - | - | - | - |
| Current Assets | 28.930 | 34.347 | - | - | - | - | - | - | - | - |
| Inventories | 0 | 0 | - | - | - | - | - | - | - | - |
| Receivables | 2.624 | 2.731 | - | - | - | - | - | - | - | - |
| Cash | 26.306 | 31.616 | - | - | - | - | - | - | - | - |
| Shareholders Funds | -89.869 | -98.298 | - | - | - | - | - | - | - | - |
| Social Capital | 45 | 45 | - | - | - | - | - | - | - | - |
| Debts | 118.799 | 132.645 | - | - | - | - | - | - | - | - |
| Income in Advance | 0 | 0 | - | - | - | - | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7020 - 7020" | |||||||||
| CAEN Financial Year |
7020
|
|||||||||
Comments - Amoun Pharmaceutical Romania Srl